We are delighted to confirm that RRI's Lead Specialty Research Physician, Dominic Pimenta, has won the Young Investigators Award at the ESC Preventive Cardiology 2022. The online event held earlier this month, 7-9 April, focused on "Implementing Innovation" in preventive cardiology.
Dr Pimenta achieved the award success for his presentation on "Cardiovascular risk factor insights into the Tesco 1.0 Dataset". The Tesco 1.0 Dataset is an open-source insight into the shopping behaviour of 16m Clubcard users in London, organised by borough of residence. We utilised this to explore whether such data correlated with population level cardiovascular outcomes, including ischaemic heart disease, stroke and covid 19 mortality. We demonstrated significant correlations with biologically plausible risk factors and protective factors, including salt and fat, and fibre. We also interesting observed an unexpected protective relationship with ready meal use and covid 19 mortality. We hope to explore this data more in the future to develop a better precision medicine approach to the dietary aspect of health and disease.
Learn more about ESC Preventive Cardiology 2022 and the award winners by visiting their website.
Authored by Georg Ferber, PhD, Dilshat Djumanov, PhD, Ulrike Lorch, MD, FFPM, Edward Jackson, BSc, MSc, PhD, MBChB, Joao Almeida Melo, James Rickard, MPharm, and Jorg Taubel, MD, FFPM, FESC.
We studied the cardiac safety of P218 using advanced QTc assessments and found doses of up to 1000mg do not prolong the QTc suggesting a low risk of drug induced arrhythmia.
Here we present the results of our recent work on the cardiac safety of cortexolone 17α-propionate (cortexolone).
12-lead resting ECGs are considered essential in clinical trials, but their limitations have led to increasing use of 12-lead Holter monitor devices.
Here we report our recent work on the cardiac safety of nolasiban.
Findings from our recent study show how cardiac ion channel blocking agents could increase the risk of sudden cardiac death in patients with type 1 diabetes, particularly in women.